Systematic review: Secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 6, 2009, Pages 577-588

  Cheung, J ^a,b,c   Zeman, M ^a,b   Van Zanten, S V ^a,b   Tandon, P ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Capital Health Edmonton   (Canada)

^c Zeidler Ledcor Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE MONONITRATE; NADOLOL; PROPRANOLOL;

ARTICLE; BAND LIGATION; BRADYCARDIA; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; DATA EXTRACTION; DIZZINESS; DRUG WITHDRAWAL; DYSPHAGIA; ENDOSCOPIC SURGERY; ESOPHAGUS HEMORRHAGE; ESOPHAGUS ULCER HEMORRHAGE; ESOPHAGUS VARICES; FATIGUE; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; LIGATION; LIVER CIRRHOSIS; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; RISK FACTOR; SECONDARY PREVENTION; SENSITIVITY ANALYSIS; SEXUAL DYSFUNCTION; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT OUTCOME; WEAKNESS;

ADRENERGIC BETA-ANTAGONISTS; COMBINED MODALITY THERAPY; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; ISOSORBIDE DINITRATE; LIGATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SECONDARY PREVENTION; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 68949198137     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04075.x     Document Type: Article

References (42)

1. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1989 320 : 983 9.
2. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001 345 : 669 81.
3. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. AASLD practice guidelines. Hepatology 2007 46 : 922 37.
4. Merkel C, Sacerdoti D, Finucci GF, et al. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. Br J Clin Pharmacol 1986 21 : 713 9.
5. Ohnishi K, Nakayama T, Saito M, et al. Effects of propranolol on portal hemodynamics in patients with chronic liver disease. Am J Gastroenterol 1985 80 : 132 5.
6. García-Pagán JC, Feu F, Bosch J, Rodés J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 1991 114 : 869 73.
7. Cheung J, Wong W, Zandieh I, et al. Acute management and secondary prophylaxis of esophageal variceal bleeding: a Western Canadian survey. Can J Gastroenterol 2006 20 : 531 4.
8. Zaman A, Hapke RJ, Flora K, Rosen HR, Benner KG. Changing compliance to the American college of gastroenterology guidelines for the management of variceal hemorrhage: a regional survey. Am J Gastroenterol 2004 99 : 645 9.
9. Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001 345 : 647 55.
10. Lo GH, Chen WC, Chen MH, et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002 123 : 728 34.
11. Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002 123 : 1013 9.
12. Romero G, Kravetz D, Argonz J, et al. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther 2006 24 : 601 11.
13. Sarin SK, Wadhawan M, Gupta R, Shahi H. Evaluation of endoscopic variceal ligation (EVL) versus propranolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and non-cirrhotic patients. Dig Dis Sci 2005 50 : 1538 47.
14. de Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005 43 : 167 76.
15. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. AASLD practice guidelines. Am J Gastroenterol 2007 102 : 2086 102.
16. Gonzalez R, Zamora J, Gomez-Camarero J, Molinero LM, Banares R, Albillos A. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 2008 149 : 109 22.
17. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996 17 : 1 12.
18. Schulz KF. Subverting randomization in controlled trials. JAMA 1995 274 : 1456 8.
19. Egger M, Smith GD, Altman DG, eds. Assessing the quality of randomized controlled trials. Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd edn. London : BMJ Publishing Group, 2001 : 87 104.
20. Gluud LL, Klingenberg S, Dimitrinka N, Gluud C. Band ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials. Am J Gastroenterol 2007 102 : 2842 8.
21. Marmo R. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. G Ital Endosc Dig 2002 25 : 109 12.
22. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mono-nitrates to prevent recurrent variceal bleeding. Gastrointest Endosc 2002 55 : 761 4.
23. Wiest R, Lock G, Messmann H. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. Z Gastroenterol 2002 40 : 547 9.
24. Aubert A, Meduri B, Fritsch J. Prevention of recurrent bleeding from esophageal varices by endoscopic ligation. Preliminary study. Gastroenterol Clin Biol 1993 17 : 403 4.
25. Evrard S, Dumonceau JM, Delhaye M, Golstein P, Deviere J, Le Moine O. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy 2003 35 : 729 35.
26. Parelon G, Guiry P, Daures JP, et al. Prevention of recurrent hemorrhage caused by the rupture of esophageal varices in cirrhotic patients. A controlled study of propranolol and clip ligation of the esophagus. Presse Med 1989 18 : 1743 7.
27. Jain A, Kumar A, Tyagi P, Sharma BC, Sarin SK. Endoscopic variceal ligation (EVL) plus propranolol (P) and isosorbide mononitrate (ISMN) versus endoscopic variceal ligation alone in secondary prophylaxis of variceal bleeding: a prospective randomized controlled trial [Abstract]. Am J Gastroenterol 2006 101 (Suppl 2) S179.
28. Gallego A, Villaneuva C, Ortiz J, et al. Preliminary results of a prospective and randomized trial comparing endoscopic ligation with nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding [Abstract]. Hepatology 1997 26 (Suppl 2) 1530.
29. Gallego A, Villanueva C, Ortiz J, et al. Endoscopic ligation compared with nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding. Preliminary results of a prospective and randomized trial [Abstract]. Gastrointest Endosc 1997 45 (Suppl S) 176.
30. Goulis J, Patch D, Greenslade L, Gerunda G, Merkel C, Burroughs AK. RCT of variceal ligation (VL) vs propranolol-iso-sorbide (PI) for variceal rebleeding with target pressure reduction: Methodological problems [Abstract]. Gut 1998 42 (Suppl 1) A19.
31. Minyana J, Gallego A, Vera JS, et al. Endoscopic ligation versus nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding. A prospective and randomized trial [Abstract]. Hepatology 1999 30 (Suppl S) 214A.
32. Romero G, Kravetz D, Argonz J, et al. Nadolol plus isosorbide mononitrate compared with banding plus low volume sclerotherapy for prevention of variceal rebleeding in patients with cirrhosis [Abstract]. Hepatology 2004 40 (Suppl 1) 204A.
33. de La Pena J, Rivero M, et al. Variceal ligation plus nadolol compared with variceal ligation after bleeding. Multicenter randomized trial. Preliminary analysis [Abstract]. Gastroenterology 2003 124 (Suppl S) A733.
34. Shiha G, Menesy A, Seef S, El Fakhry A, Khalek EA, Khalil N. Endoscopic ligation compared with propranolol and combined isosorbide mononitrate (ISMN) and propranolol to prevent recurrent variceal bleeding: A prospective randomized trial [Abstract]. Gut 2005 54 (Suppl 2) A6.
35. Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 2000 32 : 461 5.
36. de la Pena J, Enric B, Sánchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 2005 41 : 572 8.
37. Jha SK, Kumar A, Sharma BC, Sarin SK. Endoscopic variceal ligation (EVL) plus propranolol (P) and isosorbide mononitrate (ISMN) versus EVL alone in secondary prophylaxis of variceal bleeding: a prospective RCT [Abstract]. Hepatology 2007 46 (Suppl S) 250A 1A.
38. Sollano JD, Chan MM, Ismael AE, Barbaran ROP, Lim EL. Propranolol prevents rebleeding after variceal ligation [Abstract]. Gastrointest Endosc 2001 53 (Suppl S) AB143.
39. Garcia-Pagan JC, Villanueva C, Alibillos A, et al. Nadolol + isosorbide-5-mononitrate (NAD+ISMN) vs. NAD+ISMN + endoscopic band ligation in the prevention of rebleeding in patients with cirrhosis. Preliminary results of a multicenter RCT [Abstract]. J Hepatol 2006 44 (Suppl 2) S11.
40. Lo GH, Chen MH, Lai KH. A randomized, controlled trial of banding ligation plus drug therapy vs drug therapy alone in the prevention of esophageal variceal rebleeding [Abstract]. Gut 2005 54 (Suppl 7) A78.
41. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003 37 : 902 8.
42. Luca A, García-Pagán JC, Bosch J, et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997 112 : 1284 9.